CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | isotretinoin |
|
Accession: | CHEBI:6067
|
browse the term
|
Definition: | A retinoic acid that is all-trans-retinoic acid in which the double bond which is alpha,beta- to the carboxy group is isomerised to Z configuration. A synthetic retinoid, it is used for the treatment of severe cases of acne and other skin diseases. |
Synonyms: | exact_synonym: | (2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
| related_synonym: | (7E,9E,11E,13Z)-retinoic acid; 13-RA; 13-cis-Vitamin A acid; 13-cis-retinoic acid; Accutane; Amnesteem; Claravis; Formula=C20H28O2; InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-; InChIKey=SHGAZHPCJJPHSC-XFYACQKRSA-N; Neovitamin A acid; SMILES=CC(\\C=C\\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C\\C(O)=O; cis-RA; isotretinoina; isotretinoine; isotretinoino; isotretinoinum |
| xref: | Beilstein:1885770; CAS:4759-48-2; DrugBank:DB00982; Drug_Central:1508; HMDB:HMDB0006219; KEGG:D00348; LIPID_MAPS_instance:LMPR01090021 |
| xref_mesh: | MESH:D015474 |
| xref: | PMID:11606947; PMID:11866680; PMID:15304471; PMID:18077132; PMID:18788179; PMID:19568610; PMID:20482692; PMID:23676507; PMID:9807973; Patent:EP111325; Patent:US4556518; Reaxys:1885770; Wikipedia:Isotretinoin |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:169952 |
|
|
|
G |
A2m |
alpha-2-macroglobulin |
increases expression |
ISO |
Isotretinoin results in increased expression of A2M mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AACS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
EXP |
Isotretinoin results in increased expression of ABCA1 protein |
CTD |
PMID:17478430 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
[vorinostat co-treated with Isotretinoin] results in increased expression of ABCB1 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
increases expression |
EXP |
Isotretinoin results in increased expression of ABCG1 protein |
CTD |
PMID:17478430 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abhd5 |
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ABHD5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACAA1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:119,079,401...119,088,624
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACAA2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACACA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acad8 |
acyl-CoA dehydrogenase family, member 8 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACAD8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:25,382,271...25,406,429
Ensembl chr 8:25,382,273...25,406,414
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACADM mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACADVL mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACAT2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acly |
ATP citrate lyase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACLY mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Aco1 |
aconitase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACO1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Acot13 |
acyl-CoA thioesterase 13 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACOT13 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACOT2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:103,611,744...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACOX2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acp6 |
acid phosphatase 6, lysophosphatidic |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACP6 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:184,711,975...184,733,067
Ensembl chr 2:184,711,619...184,733,017
|
|
G |
Acsbg1 |
acyl-CoA synthetase bubblegum family member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACSBG1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:54,991,294...55,047,276
Ensembl chr 8:54,991,296...55,047,391
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACSL3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:80,140,996...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACSL5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SAH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Acy1 |
aminoacylase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ACY1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adgra2 |
adhesion G protein-coupled receptor A2 |
increases expression |
ISO |
Isotretinoin results in increased expression of ADGRA2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:64,932,964...64,971,433
Ensembl chr16:64,933,315...64,971,483
|
|
G |
Adgre5 |
adhesion G protein-coupled receptor E5 |
increases expression |
ISO |
Isotretinoin results in increased expression of ADGRE5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:24,397,972...24,418,648
Ensembl chr19:24,398,689...24,418,638
|
|
G |
Adgrg2 |
adhesion G protein-coupled receptor G2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ADGRG2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
increases expression |
ISO |
Isotretinoin results in increased expression of ADRA2A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Adtrp |
androgen-dependent TFPI-regulating protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ADTRP mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:22,930,012...22,993,834
Ensembl chr17:22,930,740...22,993,826
|
|
G |
Aga |
aspartylglucosaminidase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AGA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:38,504,661...38,516,607
Ensembl chr16:38,504,663...38,516,606
|
|
G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AGPAT3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358
|
|
G |
Agr2 |
anterior gradient 2, protein disulphide isomerase family member |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AGR2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
increases expression |
EXP |
Isotretinoin results in increased expression of AGTR1 mRNA; Isotretinoin results in increased expression of AGTR1 protein |
CTD |
PMID:19212007 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahsp |
alpha hemoglobin stabilizing protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AHSP mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:182,879,901...182,885,508
Ensembl chr 1:182,880,076...182,885,506
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AIFM1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AIP mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 1:201,407,287...201,419,220
Ensembl chr 1:201,407,288...201,419,122
|
|
G |
Akap11 |
A-kinase anchoring protein 11 |
increases expression |
ISO |
Isotretinoin results in increased expression of AKAP11 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:53,911,635...53,956,138
Ensembl chr15:53,911,657...53,941,605
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AKR1A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ALAS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:106,876,514...106,889,852
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Alb |
albumin |
decreases expression |
EXP |
Isotretinoin results in decreased expression of ALB protein |
CTD |
PMID:16092084 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ALCAM mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ALDH1A2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh3b2 |
aldehyde dehydrogenase 3 family, member B2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ALDH3B2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:201,250,260...201,264,699
Ensembl chr 1:201,253,157...201,264,705
|
|
G |
Aldh3b3 |
aldehyde dehydrogenase 3 family, member B3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ALDH3B2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204
|
|
G |
Alg13 |
ALG13, UDP-N-acetylglucosaminyltransferase subunit |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ALG13 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:107,885,039...107,906,264
Ensembl chr X:107,885,064...107,893,002
|
|
G |
Alox15b |
arachidonate 15-lipoxygenase, type B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ALOX15B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:53,892,496...53,901,812
Ensembl chr10:53,892,466...53,901,812
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AMACR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
|
|
G |
Ank2 |
ankyrin 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of ANK2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ANKHD1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:28,161,882...28,260,917
Ensembl chr18:28,162,311...28,268,024
|
|
G |
Ano10 |
anoctamin 10 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ANO10 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:121,841,664...121,960,739
Ensembl chr 8:121,841,665...121,962,670
|
|
G |
Ap2b1 |
adaptor related protein complex 2 subunit beta 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of AP2B1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:68,099,397...68,205,023
Ensembl chr10:68,099,547...68,205,013
|
|
G |
Ap3s2 |
adaptor related protein complex 3 subunit sigma 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of AP3S2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:133,818,825...133,859,269
Ensembl chr 1:133,818,825...133,859,322
|
|
G |
Apoc1 |
apolipoprotein C1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of APOC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apoe |
apolipoprotein E |
affects response to substance |
ISO |
APOE gene polymorphism affects the susceptibility to Isotretinoin |
CTD |
PMID:12622636 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Apool |
apolipoprotein O-like |
decreases expression |
ISO |
Isotretinoin results in decreased expression of APOOL mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:77,377,685...77,443,670
Ensembl chr X:77,377,781...77,443,900
|
|
G |
Areg |
amphiregulin |
multiple interactions |
ISO |
Isotretinoin inhibits the reaction [Calcitriol results in increased expression of AREG mRNA] |
CTD |
PMID:11237771 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arg2 |
arginase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ARG2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
increases expression |
ISO |
Isotretinoin results in increased expression of ARHGDIB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor 6 |
increases expression |
ISO |
Isotretinoin results in increased expression of ARHGEF6 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:135,145,447...135,264,636
Ensembl chr X:135,146,786...135,275,304
|
|
G |
Artn |
artemin |
multiple interactions |
ISO |
[vorinostat co-treated with Isotretinoin] results in increased expression of ARTN mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
|
|
G |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of ASAP3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:148,433,382...148,476,027
Ensembl chr 5:148,433,494...148,474,073
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
Isotretinoin affects the localization of and results in decreased activity of ATF2 protein |
CTD |
PMID:18652567 PMID:19066126 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atf5 |
activating transcription factor 5 |
multiple interactions |
ISO |
[vorinostat co-treated with Isotretinoin] results in decreased expression of ATF5 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atg4a |
autophagy related 4A, cysteine peptidase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ATG4A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:104,665,345...104,765,271
Ensembl chr X:104,665,345...104,765,268
|
|
G |
Atp2b4 |
ATPase plasma membrane Ca2+ transporting 4 |
increases expression |
ISO |
Isotretinoin results in increased expression of ATP2B4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ATP5F1C mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
|
|
G |
Atp5mc3 |
ATP synthase membrane subunit c locus 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ATP5MC3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
|
|
G |
Atp5mf |
ATP synthase membrane subunit f |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ATP5MF mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
|
|
G |
Atp5mj-ps1 |
ATP synthase membrane subunit j, pseudogene 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ATP5MJ mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:168,472,019...168,472,630
Ensembl chr 1:168,472,329...168,472,610
|
|
G |
Atp6v0b |
ATPase H+ transporting V0 subunit B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ATP6V0B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:131,423,384...131,424,900
Ensembl chr 5:131,423,387...131,426,401
|
|
G |
Atp6v0c |
ATPase H+ transporting V0 subunit C |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ATP6V0C mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,196,204...13,201,500
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ATP6V1D mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:97,656,725...97,672,211
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of BASP1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Isotretinoin results in increased expression of BAX; Isotretinoin results in increased expression of BAX protein |
CTD |
PMID:16109544 PMID:16135400 PMID:16909596 PMID:27606422 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbln |
bublin coiled coil protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BBLN mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:15,674,577...15,677,393
Ensembl chr 3:15,674,580...15,677,374
|
|
G |
Bcap29 |
B-cell receptor-associated protein 29 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BCAP29 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:48,182,702...48,222,698
Ensembl chr 6:48,182,706...48,222,720
|
|
G |
Bcap31 |
B-cell receptor-associated protein 31 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BCAP31 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:151,397,567...151,429,666
Ensembl chr X:151,397,576...151,428,506
|
|
G |
Bcat2 |
branched chain amino acid transaminase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BCAT2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:96,040,407...96,060,008
Ensembl chr 1:96,042,625...96,060,007
|
|
G |
Bckdhb |
branched chain keto acid dehydrogenase E1 subunit beta |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BCKDHB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression increases expression |
ISO |
Isotretinoin results in decreased expression of BCL2; Isotretinoin results in decreased expression of BCL2 protein Isotretinoin results in increased expression of BCL2 mRNA; Isotretinoin results in increased expression of BCL2 protein Isotretinoin results in decreased expression of BCL2; Isotretinoin results in decreased expression of BCL2 mRNA; Isotretinoin results in decreased expression of BCL2 protein |
CTD |
PMID:16109544 PMID:16909596 PMID:18380168 PMID:18652567 PMID:21159604 PMID:27606422 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
increases expression decreases expression |
ISO |
Isotretinoin results in increased expression of BCL2L1 mRNA; Isotretinoin results in increased expression of BCL2L1 protein Isotretinoin results in decreased expression of BCL2L1 protein |
CTD |
PMID:16135400 PMID:21159604 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BDH1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
|
|
G |
Bean1 |
brain expressed, associated with NEDD4, 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BEAN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:739,551...786,122
Ensembl chr19:739,551...787,537
|
|
G |
Bend5 |
BEN domain containing 5 |
increases expression |
ISO |
Isotretinoin results in increased expression of BEND5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:126,290,648...126,336,662
Ensembl chr 5:125,254,956...126,534,367
|
|
G |
Bgn |
biglycan |
increases expression |
ISO |
Isotretinoin results in increased expression of BGN mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
increases expression |
ISO |
Isotretinoin results in increased expression of BHLHE40 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BIRC5 protein |
CTD |
PMID:16135400 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blvrb |
biliverdin reductase B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BLVRB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmerb1 |
bMERB domain containing 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of BMERB1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:1,779,834...1,946,586
Ensembl chr10:1,779,835...1,946,575
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BRAF mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Bsg |
basigin (Ok blood group) |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BSG mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Btbd3 |
BTB domain containing 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of BTBD3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:125,591,490...125,619,038
|
|
G |
Btd |
biotinidase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of BTD mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
|
|
G |
C1r |
complement C1r |
increases expression |
ISO |
Isotretinoin results in increased expression of C1R mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C1s |
complement C1s |
increases expression |
ISO |
Isotretinoin results in increased expression of C1S mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C3 |
complement C3 |
increases expression |
ISO |
Isotretinoin results in increased expression of C3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cald1 |
caldesmon 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of CALD1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:63,265,781...63,446,936
Ensembl chr 4:63,265,942...63,446,932
|
|
G |
Calml3 |
calmodulin-like 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CALML3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175
|
|
G |
Casp3 |
caspase 3 |
increases cleavage increases expression |
ISO |
Isotretinoin results in increased cleavage of CASP3 protein Isotretinoin results in increased expression of CASP3; Isotretinoin results in increased expression of CASP3 protein Isotretinoin results in increased expression of CASP3; Isotretinoin results in increased expression of CASP3 mRNA |
CTD |
PMID:16109544 PMID:16135400 PMID:16157052 PMID:16575387 PMID:16909596 PMID:18380168 PMID:18652567 PMID:27606422 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases cleavage increases expression |
ISO |
Isotretinoin results in increased cleavage of CASP8 protein Isotretinoin results in increased expression of CASP8 protein |
CTD |
PMID:16135400 PMID:27606422 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
Isotretinoin results in increased expression of CASP9 protein |
CTD |
PMID:27606422 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
ISO EXP |
Isotretinoin inhibits the reaction [Benzoyl Peroxide results in decreased activity of CAT protein] Isotretinoin results in decreased activity of CAT protein |
CTD |
PMID:15225900 PMID:35752295 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cavin1 |
caveolae associated protein 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of CAVIN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:85,884,100...85,896,136
Ensembl chr10:85,889,036...85,896,120
|
|
G |
Cbx3 |
chromobox 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CBX3 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CCDC86 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:207,590,946...207,596,527
Ensembl chr 1:207,590,168...207,596,544
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
Isotretinoin results in decreased expression of CCL2 mRNA |
CTD |
PMID:15972972 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
decreases expression |
EXP |
Isotretinoin results in decreased expression of CCL3 mRNA |
CTD |
PMID:15972972 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions decreases expression |
ISO EXP |
Isotretinoin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Isotretinoin inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] Isotretinoin results in decreased expression of CCL5 mRNA |
CTD |
PMID:15972972 |
|
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CCND1 protein |
CTD |
PMID:16575387 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd2 |
Cd2 molecule |
increases expression |
ISO |
Isotretinoin results in increased expression of CD2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:188,710,895...188,724,044
Ensembl chr 2:188,710,900...188,724,026
|
|
G |
Cd247 |
Cd247 molecule |
increases expression |
ISO |
Isotretinoin results in increased expression of CD3Z mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:78,043,302...78,118,437
Ensembl chr13:78,043,307...78,122,263
|
|
G |
Cd34 |
CD34 molecule |
increases expression |
ISO |
Isotretinoin results in increased expression of CD34 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:106,480,074...106,499,462
Ensembl chr13:106,480,043...106,499,832
|
|
G |
Cd37 |
CD37 molecule |
increases expression |
ISO |
Isotretinoin results in increased expression of CD37 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:95,719,171...95,724,662
Ensembl chr 1:95,719,190...95,724,648
|
|
G |
Cd38 |
CD38 molecule |
increases expression |
ISO |
Isotretinoin results in increased expression of CD38 protein |
CTD |
PMID:16275619 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cd3d |
CD3 delta subunit of T-cell receptor complex |
increases expression |
ISO |
Isotretinoin results in increased expression of CD3D mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809
|
|
G |
Cd52 |
CD52 molecule |
increases expression |
ISO |
Isotretinoin results in increased expression of CD52 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
|
|
G |
Cd69 |
Cd69 molecule |
multiple interactions |
ISO |
[Dacarbazine co-treated with Isotretinoin] affects the reaction [IFNA2 protein results in increased expression of CD69 protein] |
CTD |
PMID:17973783 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd81 |
Cd81 molecule |
increases expression |
ISO |
Isotretinoin results in increased expression of CD81 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cda |
cytidine deaminase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CDA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:150,556,615...150,583,231
Ensembl chr 5:150,556,615...150,583,231
|
|
G |
Cdc14b |
cell division cycle 14B |
increases expression |
ISO |
Isotretinoin results in increased expression of CDC14B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:844,731...934,787
Ensembl chr17:844,685...933,235
|
|
G |
Cdh5 |
cadherin 5 |
increases expression |
ISO |
Isotretinoin results in increased expression of CDH5 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CDK5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdk5rap1 |
CDK5 regulatory subunit associated protein 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CDK5RAP1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:142,838,081...142,872,669
Ensembl chr 3:142,708,028...142,872,677
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases expression multiple interactions |
ISO |
Isotretinoin results in decreased expression of CDKN1A mRNA Isotretinoin results in increased expression of CDKN1A protein [LAQ824 co-treated with Isotretinoin] results in increased expression of CDKN1A mRNA; [LAQ824 co-treated with Isotretinoin] results in increased expression of CDKN1A protein |
CTD |
PMID:16575387 PMID:17237267 PMID:20436886 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CDKN1C mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CEACAM1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
Isotretinoin results in increased expression of CEL mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of CELF2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
|
|
G |
Cers4 |
ceramide synthase 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CERS4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:2,851,784...2,890,244
Ensembl chr12:2,851,784...2,886,828
|
|
G |
Cfap45 |
cilia and flagella associated protein 45 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CFAP45 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:84,989,474...85,012,880
Ensembl chr13:84,981,728...85,012,878
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CHI3L1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Chp1 |
calcineurin-like EF-hand protein 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CHP1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:106,536,009...106,571,255
Ensembl chr 3:106,536,004...106,571,251
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
increases expression |
ISO |
Isotretinoin results in increased expression of CHST6 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CIDEA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Ckb |
creatine kinase B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CKB mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Ckm |
creatine kinase, M-type |
increases expression |
ISO |
Isotretinoin results in increased expression of CKM protein |
CTD |
PMID:9747221 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Ckmt1 |
creatine kinase, mitochondrial 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CKMT1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:108,329,859...108,335,760
Ensembl chr 3:108,330,705...108,335,758
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CLCN3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:29,127,419...29,200,133
Ensembl chr16:29,127,419...29,200,119
|
|
G |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit X |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CLPX mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
|
|
G |
Clstn3 |
calsyntenin 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CLSTN3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CNDP2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Coch |
cochlin |
increases expression |
ISO |
Isotretinoin results in increased expression of COCH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
increases expression |
ISO |
Isotretinoin results in increased expression of COL14A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
decreases expression |
ISO |
Isotretinoin results in decreased expression of COL17A1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 1:246,530,589...246,577,632
Ensembl chr 1:246,531,367...246,577,632
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
EXP |
Isotretinoin results in decreased expression of COL1A1 mRNA; Isotretinoin results in decreased expression of COL1A1 protein |
CTD |
PMID:15972972 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
EXP |
Isotretinoin results in decreased expression of COL3A1 mRNA; Isotretinoin results in decreased expression of COL3A1 protein |
CTD |
PMID:15972972 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
increases expression |
ISO |
Isotretinoin results in increased expression of COL4A2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
increases expression |
ISO |
Isotretinoin results in increased expression of COL5A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
increases expression |
ISO |
Isotretinoin results in increased expression of COL5A2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:47,448,736...47,598,396
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
decreases expression increases expression |
ISO |
Isotretinoin results in decreased expression of COL6A1 mRNA Isotretinoin results in increased expression of COL6A1 mRNA |
CTD |
PMID:15982314 PMID:20436886 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
ISO |
Isotretinoin results in increased expression of COL6A2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
increases expression |
ISO |
Isotretinoin results in increased expression of COL6A3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Col8a2 |
collagen type VIII alpha 2 chain |
decreases expression |
ISO |
Isotretinoin results in decreased expression of COL8A2 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 5:138,586,201...138,613,627
Ensembl chr 5:138,585,999...138,612,850
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of COX5A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of COX5B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of COX6A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
|
|
G |
Cox7a2 |
cytochrome c oxidase subunit 7A2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of COX7A2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:80,716,824...80,720,922
Ensembl chr14:51,301,168...51,301,633
|
|
G |
Cox7b |
cytochrome c oxidase subunit 7B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of COX7B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:71,083,486...71,089,733
Ensembl chr X:71,083,456...71,089,732
|
|
G |
Cpd |
carboxypeptidase D |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CPD mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CPT2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
increases expression multiple interactions |
ISO |
Isotretinoin results in increased expression of CRABP2 mRNA R116010 promotes the reaction [Isotretinoin results in increased expression of CRABP2 mRNA] |
CTD |
PMID:17486130 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Crat |
carnitine O-acetyltransferase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CRAT mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases phosphorylation |
ISO |
Isotretinoin results in increased phosphorylation of CREB1 protein |
CTD |
PMID:16280361 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cript |
CXXC repeat containing interactor of PDZ3 domain |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CRIPT mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:7,581,428...7,589,384
Ensembl chr 6:7,580,703...7,589,399
|
|
G |
Crtc3 |
CREB regulated transcription coactivator 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of CRTC3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:134,552,830...134,655,929
Ensembl chr 1:134,554,696...134,655,500
|
|
G |
Cryz |
crystallin zeta |
multiple interactions |
ISO |
Isotretinoin inhibits the reaction [Benzoyl Peroxide results in decreased activity of CRYZ protein] |
CTD |
PMID:15225900 |
|
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
increases expression |
ISO |
Isotretinoin results in increased expression of CSF1R mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2 |
colony stimulating factor 2 |
decreases secretion |
EXP |
Isotretinoin results in decreased secretion of CSF2 protein |
CTD |
PMID:15972972 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Cst3 |
cystatin C |
increases expression |
ISO |
Isotretinoin results in increased expression of CST3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Cstb |
cystatin B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CSTB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:10,245,462...10,247,505
Ensembl chr20:10,245,462...10,247,526
|
|
G |
Cth |
cystathionine gamma-lyase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CTH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Cttn |
cortactin |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CTTN mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
|
|
G |
Cux2 |
cut-like homeobox 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CUX2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CXCL1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression |
ISO EXP |
Isotretinoin results in decreased expression of CXCL10 mRNA |
CTD |
PMID:15972972 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression |
ISO |
Isotretinoin results in increased expression of CXCL12 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CXCL1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyb5a |
cytochrome b5 type A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CYB5A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of CYP26A1 mRNA |
CTD |
PMID:16194896 PMID:17486130 PMID:18769122 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
multiple interactions increases expression |
ISO |
R116010 promotes the reaction [Isotretinoin results in increased expression of CYP26B1 mRNA] |
CTD |
PMID:17486130 PMID:18769122 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases activity |
ISO |
[Isotretinoin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Isotretinoin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] Isotretinoin results in increased activity of CYP3A4 protein |
CTD |
PMID:16632523 PMID:25455453 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CYP4F3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
|
|
G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CYP4F8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:12,030,276...12,058,020
Ensembl chr 7:12,030,301...12,057,782
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CYP51A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Dbi |
diazepam binding inhibitor |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DBI mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dbn1 |
drebrin 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of DBN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DBT mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DCXR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:106,006,404...106,008,294
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DDC mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddo |
D-aspartate oxidase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DDO mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:44,090,823...44,109,962
Ensembl chr20:44,090,914...44,133,095
|
|
G |
Ddt |
D-dopachrome tautomerase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DDT mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Dennd5a |
DENN domain containing 5A |
increases expression |
ISO |
Isotretinoin results in increased expression of DENND5A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:163,928,183...163,994,207
Ensembl chr 1:163,928,183...163,994,316
|
|
G |
Desi1 |
desumoylating isopeptidase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DESI1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:113,519,974...113,542,834
Ensembl chr 7:113,519,980...113,542,845
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DHCR24 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:121,344,637...121,368,853
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DHCR7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhfr |
dihydrofolate reductase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DHFR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Dhrs11 |
dehydrogenase/reductase 11 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DHRS11 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of DHRS3 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhrs7b |
dehydrogenase/reductase 7B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DHRS7B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076
|
|
G |
Dhrs9 |
dehydrogenase/reductase 9 |
multiple interactions decreases expression |
ISO |
[vorinostat co-treated with Isotretinoin] results in increased expression of DHRS9 mRNA Isotretinoin results in decreased expression of DHRS9 mRNA |
CTD |
PMID:18769122 PMID:20436886 |
|
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
|
|
G |
Diras3 |
DIRAS family GTPase 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DIRAS3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:130,524,972...130,527,690
Ensembl chr 6:130,524,742...130,530,825
|
|
G |
Dixdc1 |
DIX domain containing 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of DIXDC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:51,007,835...51,081,191
Ensembl chr 8:51,007,838...51,081,090
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DLD mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dlg5 |
discs large MAGUK scaffold protein 5 |
increases expression |
ISO |
Isotretinoin results in increased expression of DLG5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:75,786...209,735
Ensembl chr15:75,786...187,837
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
increases expression |
ISO |
Isotretinoin results in increased expression of DLST protein |
CTD |
PMID:15982314 |
|
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DNAJA3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:10,855,510...10,880,175
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajc15 |
DnaJ heat shock protein family (Hsp40) member C15 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DNAJC15 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DNAJC3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:96,025,729...96,065,114
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dnase1 |
deoxyribonuclease 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of DNASE1 protein |
CTD |
PMID:15982314 |
|
NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869
|
|
G |
Dnase1l2 |
deoxyribonuclease 1 like 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DNASE1L2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:13,471,850...13,473,447
Ensembl chr10:13,471,479...13,473,763
|
|
G |
Dnm1 |
dynamin 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of DNM1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:15,604,782...15,648,654
Ensembl chr 3:15,604,784...15,648,538
|
|
G |
Dop1b |
DOP1 leucine zipper like protein B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DOP1B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:33,024,376...33,125,931
Ensembl chr11:33,024,411...33,125,931
|
|
G |
Dpp3 |
dipeptidylpeptidase 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DPP3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:202,204,683...202,228,501
Ensembl chr 1:202,204,693...202,228,541
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of DPYSL2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Drp2 |
dystrophin related protein 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DRP2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:97,607,577...97,658,115
Ensembl chr X:97,607,719...97,655,684
|
|
G |
Dsc1 |
desmocollin 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DSC1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
|
|
G |
Dsc2 |
desmocollin 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DSC2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
increases expression |
ISO |
Isotretinoin results in increased expression of DUSP10 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
|
|
G |
Dusp11 |
dual specificity phosphatase 11 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DUSP11 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of DUSP4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
|
|
G |
E2f8 |
E2F transcription factor 8 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of E2F8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EBP mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ECH1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ECHDC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:28,476,354...28,507,173
Ensembl chr 1:28,476,200...28,507,319
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ECI1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of EFEMP2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EGFR mRNA |
CTD |
PMID:15982314 |
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr3 |
early growth response 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EGR3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
|
|
G |
Ei24 |
EI24, autophagy associated transmembrane protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EI24 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
|
|
G |
Eif2b3 |
eukaryotic translation initiation factor 2B subunit gamma |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EIF2B3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:130,492,167...130,558,692
Ensembl chr 5:130,492,220...130,563,332
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EIF4E mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EIF4EBP2 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr20:29,379,444...29,400,131
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Ell2 |
elongation factor for RNA polymerase II 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ELL2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
|
|
G |
Elovl1 |
ELOVL fatty acid elongase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ELOVL1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
|
|
G |
Elovl4 |
ELOVL fatty acid elongase 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ELOVL4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:84,702,916...84,729,466
Ensembl chr 8:84,702,362...84,729,697
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ELOVL5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:78,790,799...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of EMP1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ERCC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Erg28 |
ergosterol biosynthesis 28 homolog |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ERG28 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
|
|
G |
Esr2 |
estrogen receptor 2 |
decreases expression |
EXP |
Isotretinoin results in decreased expression of ESR2 mRNA |
CTD |
PMID:19041696 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ETFDH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Etnk1 |
ethanolamine kinase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ETNK1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
|
|
G |
Exoc7 |
exocyst complex component 7 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EXO70 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:101,521,640...101,563,123
Ensembl chr10:101,520,927...101,540,561
|
|
G |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of EYA1 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 5:4,863,501...5,101,483
Ensembl chr 5:4,955,543...5,101,483
|
|
G |
Fa2h |
fatty acid 2-hydroxylase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FA2H mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:39,312,904...39,364,153
Ensembl chr19:39,312,906...39,364,153
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
EXP |
Isotretinoin results in increased expression of FABP4 mRNA |
CTD |
PMID:19212007 |
|
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FABP5 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fabp6 |
fatty acid binding protein 6 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FABP6 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:28,063,603...28,068,276
Ensembl chr10:28,063,603...28,068,282
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FABP7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FADS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FADS2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fam149a |
family with sequence similarity 149, member A |
increases expression |
ISO |
Isotretinoin results in increased expression of FAM149A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:46,855,377...46,914,553
Ensembl chr16:46,854,635...46,912,066
|
|
G |
Fam3c |
FAM3 metabolism regulating signaling molecule C |
increases expression decreases expression |
ISO |
Isotretinoin results in increased expression of FAM3C mRNA Isotretinoin results in decreased expression of FAM3C mRNA |
CTD |
PMID:15982314 PMID:20436886 |
|
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
|
|
G |
Far2 |
fatty acyl CoA reductase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FAR2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:180,973,968...181,087,862
Ensembl chr 4:181,007,622...181,087,255
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FASN mRNA |
CTD |
PMID:15982314 PMID:20436886 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FASTK mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of FBLN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FBP1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbp2 |
fructose-bisphosphatase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FBP2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
|
|
G |
Fbxl7 |
F-box and leucine-rich repeat protein 7 |
increases expression |
ISO |
Isotretinoin results in increased expression of FBXL7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:77,139,775...77,509,223
Ensembl chr 2:77,140,826...77,509,223
|
|
G |
Fbxo9 |
f-box protein 9 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FBXO9 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FDFT1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FDPS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fez2 |
fasciculation and elongation protein zeta 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of FEZ2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FGF1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of FGFR1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:66,492,445...66,546,731
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of FGFR3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fh |
fumarate hydratase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Fkbp10 |
FKBP prolyl isomerase 10 |
increases expression |
ISO |
Isotretinoin results in increased expression of FKBP10 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:85,345,434...85,357,998
Ensembl chr10:85,346,126...85,427,330
|
|
G |
Fkbp8 |
FKBP prolyl isomerase 8 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FKBP8 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
|
|
G |
Flg |
filaggrin |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FLG mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:178,888,688...178,912,731
|
|
G |
Flna |
filamin A |
increases expression |
ISO |
Isotretinoin results in increased expression of FLNA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Flt3lg |
Fms related receptor tyrosine kinase 3 ligand |
increases expression |
ISO |
Isotretinoin results in increased expression of FLT3LG mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:95,615,056...95,620,463
Ensembl chr 1:95,609,370...95,620,463
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of FN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Isotretinoin affects the localization of and results in decreased activity of FOS protein |
CTD |
PMID:18652567 PMID:19066126 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FOSB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Foxc2 |
forkhead box C2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FOXC2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr19:49,186,034...49,188,736
Ensembl chr19:49,185,662...49,188,737
|
|
G |
Foxd1 |
forkhead box D1 |
increases expression |
ISO |
Isotretinoin results in increased expression of FOXD1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:29,702,558...29,704,978
Ensembl chr 2:29,702,558...29,704,978
|
|
G |
Fut8 |
fucosyltransferase 8 |
increases expression |
ISO |
Isotretinoin results in increased expression of FUT8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:95,948,230...96,176,677
Ensembl chr 6:95,949,991...96,176,677
|
|
G |
Fyb1 |
FYN binding protein 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of FYB1 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 2:55,621,585...55,781,206
Ensembl chr 2:55,632,698...55,779,629
|
|
G |
Fzd5 |
frizzled class receptor 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of FZD5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:66,117,370...66,119,127
Ensembl chr 9:66,113,112...66,121,457
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases expression increases expression multiple interactions |
ISO |
Isotretinoin results in decreased expression of G6PD mRNA Isotretinoin results in increased expression of G6PD mRNA Isotretinoin inhibits the reaction [Benzoyl Peroxide results in decreased activity of G6PD protein] |
CTD |
PMID:15225900 PMID:15982314 PMID:20436886 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabra4 |
gamma-aminobutyric acid type A receptor subunit alpha 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GABRA4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844
|
|
G |
Gal |
galanin and GMAP prepropeptide |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GAL mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Gata3 |
GATA binding protein 3 |
multiple interactions |
ISO |
[vorinostat co-treated with Isotretinoin] results in increased expression of GATA3 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GATD3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gba |
glucosylceramidase beta |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GBA1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:174,609,437...174,615,457
Ensembl chr 2:174,609,403...174,618,263
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GBE1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GCLM mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
Isotretinoin results in increased expression of GCNT3 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gcsh |
glycine cleavage system protein H |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GCSH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:45,036,013...45,046,770
Ensembl chr19:45,036,011...45,046,792
|
|
G |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GDAP1L1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:152,110,225...152,129,693
Ensembl chr 3:152,110,253...152,128,711
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Isotretinoin results in increased expression of GDF15 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr16:18,805,312...18,807,893
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdf2 |
growth differentiation factor 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of GDF2 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr16:9,255,430...9,261,429
Ensembl chr16:9,255,430...9,261,429
|
|
G |
Ggcx |
gamma-glutamyl carboxylase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GGCX mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:104,469,737...104,485,631
Ensembl chr 4:104,469,765...104,487,063
|
|
G |
Ggps1 |
geranylgeranyl diphosphate synthase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GGPS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:51,263,262...51,282,471
Ensembl chr17:51,263,263...51,276,220
|
|
G |
Ghitm |
growth hormone inducible transmembrane protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GHITM mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
|
|
G |
Gins1 |
GINS complex subunit 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GINS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:139,724,513...139,745,930
Ensembl chr 3:139,724,490...139,745,936
|
|
G |
Gk |
glycerol kinase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GK mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Gldc |
glycine decarboxylase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GLDC mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:227,883,247...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glrx2 |
glutaredoxin 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GLRX2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:55,481,875...55,504,737
Ensembl chr13:55,482,694...55,492,831
|
|
G |
Glrx5 |
glutaredoxin 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GLRX5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:123,988,169...123,998,545
Ensembl chr 6:123,988,134...123,998,545
|
|
G |
Glul |
glutamate-ammonia ligase |
increases expression |
ISO |
Isotretinoin results in increased expression of GLUL mRNA |
CTD |
PMID:15982314 |
|
NCBI chr13:65,969,064...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gng4 |
G protein subunit gamma 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GNG4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
|
|
G |
Gnpat |
glyceronephosphate O-acyltransferase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GNPAT mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361
|
|
G |
Gpr143 |
G protein-coupled receptor 143 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GPR143 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:22,002,914...22,027,720
Ensembl chr X:22,002,914...22,027,715
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of GPX2 mRNA |
CTD |
PMID:15623509 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GPX3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GRB7 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Grpel1 |
GrpE-like 1, mitochondrial |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GRPEL1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
Isotretinoin inhibits the reaction [Benzoyl Peroxide results in decreased activity of GSR protein] |
CTD |
PMID:15225900 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GSTM1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions affects metabolic processing |
ISO |
Ethacrynic Acid inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin]; S-decylglutathione inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin] |
CTD |
PMID:9806904 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of GSTZ1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H1-2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:41,391,106...41,392,611
Ensembl chr17:41,388,477...41,392,635
|
|
G |
H2ac25 |
H2A clustered histone 25 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2AC25 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:43,733,702...43,735,254
Ensembl chr10:43,733,668...43,744,874
|
|
G |
H2ax |
H2A.X variant histone |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2AX mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
H2bc12 |
H2B clustered histone 12 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2BC12 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:42,485,746...42,486,126
|
|
G |
H2bc6 |
H2B clustered histone 6 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2BC6 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:41,520,767...41,521,240
|
|
G |
H2bc9 |
H2B clustered histone 9 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2BC9 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:42,470,593...42,478,605
|
|
G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HADH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HAO2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
ISO |
Isotretinoin results in increased expression of HBEGF mRNA |
CTD |
PMID:15982314 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of HCLS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014
|
|
G |
Hcn3 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HCN3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:174,551,866...174,567,459
Ensembl chr 2:174,551,680...174,565,966
|
|
G |
Hgd |
homogentisate 1, 2-dioxygenase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HGD mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:63,086,750...63,138,325
Ensembl chr11:63,086,752...63,138,323
|
|
G |
Hgf |
hepatocyte growth factor |
decreases expression decreases secretion |
ISO |
Isotretinoin results in decreased expression of HGF mRNA Isotretinoin results in decreased secretion of HGF protein |
CTD |
PMID:11223164 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hibch |
3-hydroxyisobutyryl-CoA hydrolase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HIBCH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
|
|
G |
Hilpda |
hypoxia inducible lipid droplet-associated |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HILPDA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:57,871,076...57,875,206
Ensembl chr 4:57,871,110...57,874,557
|
|
G |
Hip1 |
huntingtin interacting protein 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of HIP1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:21,133,319...21,267,796
Ensembl chr12:21,133,406...21,267,725
|
|
G |
Hist1h2af |
histone cluster 1 H2A family member F |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2AC8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:41,379,404...41,379,796
Ensembl chr17:41,379,404...41,379,796
|
|
G |
Hist1h2ah |
histone cluster 1 H2A family member H |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2AC11 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:41,384,521...41,385,018
|
|
G |
Hist1h2bc |
histone cluster 1, H2bc |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2BC4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:42,692,335...42,696,860
Ensembl chr17:42,694,723...42,696,642
|
|
G |
Hist1h2bd |
histone cluster 1 H2B family member D |
decreases expression |
ISO |
Isotretinoin results in decreased expression of H2BC5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:42,792,887...42,793,268
|
|
G |
Hlcs |
holocarboxylase synthetase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HLCS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HMGCR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HSD11B1 mRNA |
CTD |
PMID:15982314 PMID:20436886 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd17b12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HSD17B12 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:79,990,048...80,113,556
Ensembl chr 3:79,990,056...80,113,617
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HSD17B7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HSP90B1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HSPA9 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HSPD1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HTR1A protein |
CTD |
PMID:27606422 |
|
NCBI chr 2:36,694,174...36,695,442
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HTR1B protein |
CTD |
PMID:27606422 |
|
NCBI chr 8:82,513,572...82,534,892
Ensembl chr 8:82,517,360...82,534,549
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of HTRA1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Hus1 |
HUS1 checkpoint clamp component |
decreases expression |
ISO |
Isotretinoin results in decreased expression of HUS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:83,688,702...83,703,466
Ensembl chr14:83,688,708...83,703,442
|
|
G |
Icam2 |
intercellular adhesion molecule 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of ICAM2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IDH1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IDI1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier3 |
immediate early response 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IER3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi35 |
interferon-induced protein 35 |
increases expression |
ISO |
Isotretinoin results in increased expression of IFI35 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of IFITM1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IFRD1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Ift20 |
intraflagellar transport 20 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IFT20 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:63,432,597...63,438,125
Ensembl chr10:63,432,633...63,438,124
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of IGF1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of IGFBP3 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
increases expression |
ISO |
Isotretinoin results in increased expression of IGFBP4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
increases expression |
ISO |
Isotretinoin results in increased expression of IGFBP5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Il10 |
interleukin 10 |
decreases expression decreases secretion |
EXP |
Isotretinoin results in decreased expression of IL10 mRNA Isotretinoin results in decreased secretion of IL10 protein |
CTD |
PMID:15972972 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IL10RA mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IL13RA1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:115,348,860...115,408,682
Ensembl chr X:115,348,860...115,408,681
|
|
G |
Il1a |
interleukin 1 alpha |
decreases secretion |
EXP |
Isotretinoin results in decreased secretion of IL1A protein |
CTD |
PMID:15972972 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression increases expression multiple interactions decreases secretion |
ISO EXP |
Isotretinoin results in decreased expression of IL1B mRNA Isotretinoin results in increased expression of IL1B mRNA [vorinostat co-treated with Isotretinoin] results in increased expression of IL1B mRNA Isotretinoin results in decreased secretion of IL1B protein |
CTD |
PMID:15972972 PMID:15982314 PMID:18769122 PMID:20436886 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IL1R2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il2 |
interleukin 2 |
decreases secretion |
EXP |
Isotretinoin results in decreased secretion of IL2 protein |
CTD |
PMID:15972972 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il24 |
interleukin 24 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of IL24 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il4 |
interleukin 4 |
decreases secretion |
EXP |
Isotretinoin results in decreased secretion of IL4 protein |
CTD |
PMID:15972972 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
decreases expression decreases secretion |
ISO EXP |
Isotretinoin results in decreased expression of IL6 mRNA Isotretinoin results in decreased secretion of IL6 protein |
CTD |
PMID:15972972 PMID:17033190 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inpp4b |
inositol polyphosphate-4-phosphatase type II B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of INPP4B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634
|
|
G |
Insig1 |
insulin induced gene 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of INSIG1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions |
ISO |
Isotretinoin promotes the reaction [Dacarbazine results in increased expression of IRF1 mRNA] |
CTD |
PMID:17973783 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Isca1 |
iron-sulfur cluster assembly 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ISCA1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:4,905,291...4,917,955
Ensembl chr17:4,905,287...4,917,955
|
|
G |
Islr |
immunoglobulin superfamily containing leucine-rich repeat |
increases expression |
ISO |
Isotretinoin results in increased expression of ISLR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:58,571,155...58,574,128
Ensembl chr 8:58,570,777...58,574,130
|
|
G |
Isoc1 |
isochorismatase domain containing 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ISOC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:52,158,790...52,179,206
Ensembl chr18:52,158,790...52,178,703
|
|
G |
Itga4 |
integrin subunit alpha 4 |
increases expression |
ISO |
Isotretinoin results in increased expression of ITGA4 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itgav |
integrin subunit alpha V |
increases expression |
ISO |
Isotretinoin results in increased expression of ITGAV mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:68,838,524...68,926,653
Ensembl chr 3:68,838,189...68,926,639
|
|
G |
Itgb2 |
integrin subunit beta 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of ITGB2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Jak1 |
Janus kinase 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of JAK1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Kank2 |
KN motif and ankyrin repeat domains 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of KANK2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900
|
|
G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KCNJ15 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
|
|
G |
Kcnk1 |
potassium two pore domain channel subfamily K member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KCNK1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:53,959,411...53,997,726
Ensembl chr19:53,959,657...53,997,724
|
|
G |
Kctd12 |
potassium channel tetramerization domain containing 12 |
increases expression |
ISO |
Isotretinoin results in increased expression of KCTD12 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:79,800,077...79,806,064
Ensembl chr15:79,801,191...79,806,282
|
|
G |
Klhdc4 |
kelch domain containing 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KLHDC4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:49,860,975...49,894,027
Ensembl chr19:49,860,967...49,894,868
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KRAS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krt1 |
keratin 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KRT1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
|
|
G |
Krt10 |
keratin 10 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KRT10 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
|
|
G |
Krt14 |
keratin 14 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KRT14 mRNA; Isotretinoin results in decreased expression of KRT14 protein |
CTD |
PMID:15982314 |
|
NCBI chr10:85,137,932...85,141,990
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt15 |
keratin 15 |
increases expression |
ISO |
Isotretinoin results in increased expression of KRT15 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt16 |
keratin 16 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KRT16 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:85,168,357...85,171,744
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt17 |
keratin 17 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KRT17 mRNA; Isotretinoin results in decreased expression of KRT17 protein |
CTD |
PMID:15982314 PMID:18769122 |
|
NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
|
|
G |
Krt19 |
keratin 19 |
increases expression |
ISO |
Isotretinoin results in increased expression of KRT19 mRNA; Isotretinoin results in increased expression of KRT19 protein |
CTD |
PMID:15982314 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt5 |
keratin 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KRT5 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 7:132,846,355...132,851,986
Ensembl chr 7:132,846,136...132,851,850
|
|
G |
Krt7 |
keratin 7 |
increases expression |
ISO |
Isotretinoin results in increased expression of KRT7 mRNA; Isotretinoin results in increased expression of KRT7 protein |
CTD |
PMID:15982314 |
|
NCBI chr 7:132,528,863...132,545,052
Ensembl chr 7:132,528,895...132,545,052
|
|
G |
Krt75 |
keratin 75 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of KRT75 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 7:132,687,101...132,697,360
Ensembl chr 7:132,688,237...132,697,345
|
|
G |
Lactb2 |
lactamase, beta 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of LACTB2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
|
|
G |
Lage3 |
L antigen family, member 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of LAGE3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:152,138,209...152,139,632
Ensembl chr X:152,138,218...152,139,632
|
|
G |
Lama2 |
laminin subunit alpha 2 |
decreases expression increases expression |
ISO |
Isotretinoin results in decreased expression of LAMA2 mRNA Isotretinoin results in increased expression of LAMA2 mRNA |
CTD |
PMID:15982314 PMID:20436886 |
|
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
|
|
G |
Lama3 |
laminin subunit alpha 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of LAMA3 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Lamc1 |
laminin subunit gamma 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of LAMC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
|
|
G |
Lamc3 |
laminin subunit gamma 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of LAMC3 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 3:15,165,220...15,226,697
Ensembl chr 3:15,165,220...15,226,697
|
|
G |
Laptm5 |
lysosomal protein transmembrane 5 |
increases expression |
ISO |
Isotretinoin results in increased expression of LAPTM5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
|
|
G |
Larp4 |
La ribonucleoprotein 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of LARP4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:131,104,470...131,152,692
Ensembl chr 7:131,101,564...131,150,811
|
|
G |
Lck |
LCK proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
Isotretinoin results in increased expression of LCK mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:141,888,319...141,916,992
Ensembl chr 5:141,888,326...141,903,794
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of LCN2 mRNA |
CTD |
PMID:15982314 PMID:18769122 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lcp2 |
lymphocyte cytosolic protein 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of LCP2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:18,642,600...18,689,562
Ensembl chr10:18,642,658...18,689,559
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
ISO |
Isotretinoin results in decreased expression of LDLR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lep |
leptin |
increases expression |
EXP |
Isotretinoin results in increased expression of LEP mRNA |
CTD |
PMID:19212007 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhfpl6 |
LHFPL tetraspan subfamily member 6 |
increases expression |
ISO |
Isotretinoin results in increased expression of LHFPL6 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:137,126,485...137,324,442
Ensembl chr 2:137,126,509...137,324,443
|
|
G |
Limch1 |
LIM and calponin homology domains 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of LIMCH1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:41,112,579...41,425,185
Ensembl chr14:41,114,803...41,425,191
|
|
G |
Lipc |
lipase C, hepatic type |
increases expression |
ISO |
Isotretinoin results in increased expression of LIPC mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lmnb1 |
lamin B1 |
increases expression |
ISO |
Isotretinoin results in increased expression of LMNB1 protein |
CTD |
PMID:15982314 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lmo2 |
LIM domain only 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of LMO2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:90,355,234...90,377,970
Ensembl chr 3:90,365,883...90,377,953
|
|
G |
Loxl2 |
lysyl oxidase-like 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of LOXL2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
|
|
G |
Lpcat3 |
lysophosphatidylcholine acyltransferase 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of LPCAT3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:157,468,397...157,509,889
Ensembl chr 4:157,468,290...157,509,880
|
|
G |
Lpin1 |
lipin 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of LPIN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lrat |
lecithin retinol acyltransferase |
increases expression |
ISO |
Isotretinoin results in increased expression of LRAT protein |
CTD |
PMID:15982314 |
|
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
|
|
G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of LTBP1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
|
|
G |
Lyn |
LYN proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
Isotretinoin results in increased expression of LYN mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
|
|
G |
Maff |
MAF bZIP transcription factor F |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MAFF mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:110,912,499...110,923,851
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Man1a1 |
mannosidase, alpha, class 1A, member 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of MAN1A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:33,202,509...33,385,747
Ensembl chr20:33,202,517...33,385,824
|
|
G |
Map4 |
microtubule-associated protein 4 |
increases expression |
ISO |
Isotretinoin results in increased expression of MAP4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
|
|
G |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MBOAT2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:41,471,135...41,597,599
Ensembl chr 6:41,471,161...41,593,485
|
|
G |
Mc5r |
melanocortin 5 receptor |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MC5R mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:61,915,188...61,920,229
Ensembl chr18:61,915,188...61,920,229
|
|
G |
Mcat |
malonyl-CoA-acyl carrier protein transacylase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MCAT mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:114,693,612...114,705,677
Ensembl chr 7:114,693,612...114,704,542
|
|
G |
Mccc1 |
methylcrotonyl-CoA carboxylase subunit 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MCCC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:118,799,147...118,851,181
Ensembl chr 2:118,799,150...118,851,222
|
|
G |
Mccc2 |
methylcrotonyl-CoA carboxylase subunit 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MCCC2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
|
|
G |
Mcfd2 |
multiple coagulation factor deficiency 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MCFD2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:7,274,469...7,285,841
Ensembl chr 6:7,274,469...7,285,841
|
|
G |
Mcts1 |
MCTS1, re-initiation and release factor |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MCTS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:117,350,723...117,362,504
Ensembl chr X:117,350,889...117,362,504
|
|
G |
Mcur1 |
mitochondrial calcium uniporter regulator 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MCUR1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:21,142,526...21,159,651
Ensembl chr17:21,141,602...21,159,651
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MDH1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
|
|
G |
Me1 |
malic enzyme 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ME1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mecr |
mitochondrial trans-2-enoyl-CoA reductase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MECR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:144,029,684...144,056,373
Ensembl chr 5:144,029,731...144,055,863
|
|
G |
Med8 |
mediator complex subunit 8 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MED8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:131,948,632...131,949,516
Ensembl chr 5:131,943,982...131,950,305
|
|
G |
Mef2c |
myocyte enhancer factor 2C |
increases expression |
ISO |
Isotretinoin results in increased expression of MEF2C mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880
|
|
G |
Meox1 |
mesenchyme homeobox 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MEOX1 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
|
|
G |
Mesp2 |
mesoderm posterior bHLH transcription factor 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MESP2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 1:133,756,601...133,759,207
Ensembl chr 1:133,756,601...133,759,198
|
|
G |
Mfap2 |
microfibril associated protein 2 |
decreases expression increases expression |
ISO |
Isotretinoin results in decreased expression of MFAP2 mRNA Isotretinoin results in increased expression of MFAP2 mRNA |
CTD |
PMID:15982314 PMID:20436886 |
|
NCBI chr 5:153,312,068...153,320,266
Ensembl chr 5:153,314,711...153,320,259
|
|
G |
Mfap3l |
microfibril associated protein 3 like |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MFAP3L mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:29,411,643...29,454,665
Ensembl chr16:29,415,849...29,430,863
|
|
G |
Mfap4 |
microfibril associated protein 4 |
increases expression |
ISO |
Isotretinoin results in increased expression of MFAP4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
|
|
G |
Mlana |
melan-A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MLANA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:227,469,537...227,483,343
Ensembl chr 1:227,469,537...227,483,343
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MMP10 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions decreases expression |
ISO |
Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP13 mRNA]; Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP13 protein] Isotretinoin results in decreased expression of MMP13 protein |
CTD |
PMID:16185265 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions increases expression |
ISO |
Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP2 mRNA]; Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP2 protein] Isotretinoin results in increased expression of MMP2 mRNA |
CTD |
PMID:16185265 PMID:20436886 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp23 |
matrix metallopeptidase 23 |
increases expression |
ISO |
Isotretinoin results in increased expression of MMP23B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:166,239,643...166,242,734
Ensembl chr 5:166,239,644...166,242,433
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP9 mRNA]; Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP9 protein] Isotretinoin results in decreased expression of MMP9 protein |
CTD |
PMID:16185265 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mocos |
molybdenum cofactor sulfurase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MOCOS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:15,931,654...15,977,415
Ensembl chr18:15,931,654...15,977,187
|
|
G |
Mospd1 |
motile sperm domain containing 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MOSPD1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:133,100,200...133,127,960
Ensembl chr X:133,100,422...133,127,908 Ensembl chr 1:133,100,422...133,127,908
|
|
G |
Mpc1 |
mitochondrial pyruvate carrier 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MPC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:52,437,745...52,449,369
Ensembl chr 1:52,437,741...52,449,400
|
|
G |
Mpc2 |
mitochondrial pyruvate carrier 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MPC2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:77,728,176...77,747,664
Ensembl chr13:77,728,250...77,747,664
|
|
G |
Mrpl33 |
mitochondrial ribosomal protein L33 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MRPL33 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:24,825,804...24,834,061
Ensembl chr 6:24,825,827...24,833,834
|
|
G |
Mrps16 |
mitochondrial ribosomal protein S16 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MRPS16 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:3,918,621...3,921,024
Ensembl chr15:3,918,615...3,921,656
|
|
G |
Mrps18a |
mitochondrial ribosomal protein S18A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MRPS18A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:14,853,322...14,869,819
Ensembl chr 9:14,853,291...14,869,835
|
|
G |
Mrps33 |
mitochondrial ribosomal protein S33 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MRPS33 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:68,596,729...68,605,547
Ensembl chr 4:68,596,729...68,605,428
|
|
G |
Mrs2 |
magnesium transporter MRS2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MRS2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:40,063,924...40,087,073
Ensembl chr17:40,063,962...40,081,887
|
|
G |
Mrtfb |
myocardin related transcription factor B |
increases expression |
ISO |
Isotretinoin results in increased expression of MRTFB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:1,116,315...1,278,106
Ensembl chr10:1,116,310...1,277,897
|
|
G |
Msmb |
microseminoprotein, beta |
increases expression |
ISO |
Isotretinoin results in increased expression of MSMB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MSMO1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Msrb1 |
methionine sulfoxide reductase B1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MSRB1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
|
|
G |
Mtch2 |
mitochondrial carrier 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MTCH2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:76,830,549...76,850,189
Ensembl chr 3:76,830,413...76,850,189
|
|
G |
Mto1 |
mitochondrial tRNA translation optimization 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MTO1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:79,309,681...79,335,231
Ensembl chr 8:79,309,982...79,335,231
|
|
G |
Mtx1 |
Metaxin 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MTX1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:174,615,461...174,620,982
|
|
G |
Muc1 |
mucin 1, cell surface associated |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MUC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:174,635,559...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Mvd |
mevalonate diphosphate decarboxylase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MVD mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:50,496,366...50,506,389
Ensembl chr19:50,496,367...50,507,971
|
|
G |
Mvk |
mevalonate kinase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MVK mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:42,141,391...42,158,858
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Mycbp |
Myc binding protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MYCBP mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:136,135,955...136,143,163
Ensembl chr 5:136,135,931...136,145,616
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases expression multiple interactions |
ISO |
Isotretinoin results in decreased expression of MYCN mRNA R116010 promotes the reaction [Isotretinoin results in decreased expression of MYCN mRNA] |
CTD |
PMID:17486130 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Myl4 |
myosin, light chain 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MYL4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
|
|
G |
Myod1 |
myogenic differentiation 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of MYOD1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
|
|
G |
Nadk |
NAD kinase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NADK mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:166,145,708...166,176,328
Ensembl chr 5:166,145,481...166,176,322
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NAMPT mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nbn |
nibrin |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NBN mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
|
|
G |
Ndufa3 |
NADH:ubiquinone oxidoreductase subunit A3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NDUFA3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:65,597,562...65,600,242
Ensembl chr 1:65,597,578...65,600,235
|
|
G |
Ndufaf1 |
NADH:ubiquinone oxidoreductase complex assembly factor 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of CIA30 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:106,639,025...106,650,549
Ensembl chr 3:106,639,851...106,650,212
|
|
G |
Ndufb3 |
NADH:ubiquinone oxidoreductase subunit B3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NDUFB3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:60,129,240...60,139,452
Ensembl chr 9:60,129,154...60,139,446
|
|
G |
Ndufc2 |
NADH:ubiquinone oxidoreductase subunit C2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NDUFC2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:151,711,965...151,718,188
Ensembl chr 1:151,711,901...151,718,189
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NDUFS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufs3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NDUFS3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:76,876,646...76,883,824
Ensembl chr 3:76,876,646...76,883,824
|
|
G |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NDUFS7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
|
|
G |
Ndufs8 |
NADH:ubiquinone oxidoreductase core subunit S8 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NDUFS8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:201,140,585...201,144,573
Ensembl chr 1:201,140,585...201,144,511
|
|
G |
Ndufv2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NDUFV2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
increases expression |
ISO |
Isotretinoin results in increased expression of NEDD9 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
|
|
G |
Nefl |
neurofilament light chain |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NEFL mRNA |
CTD |
PMID:15982314 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Neurog2 |
neurogenin 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of NEUROG2 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 2:216,092,641...216,095,276
Ensembl chr 2:216,093,363...216,094,154
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Isotretinoin affects the localization of and results in decreased activity of NFKB1 protein |
CTD |
PMID:18652567 PMID:19066126 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nit2 |
nitrilase family, member 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NIT2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:43,363,839...43,378,713
Ensembl chr11:43,363,985...43,375,024
|
|
G |
Nop16 |
NOP16 nucleolar protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NOP16 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:10,022,950...10,027,867
Ensembl chr17:10,022,932...10,027,867
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NPC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
|
|
G |
Npl |
N-acetylneuraminate pyruvate lyase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NPL mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:65,655,099...65,697,464
Ensembl chr13:65,655,118...65,697,372
|
|
G |
Nqo2 |
N-ribosyldihydronicotinamide:quinone reductase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NQO2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
Isotretinoin inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein]; Isotretinoin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO |
[Isotretinoin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Isotretinoin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:16632523 PMID:25455453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of NR2F1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:8,040,377...8,050,123
|
|
G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NSDHL mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:150,775,080...150,807,142
|
|
G |
Ntan1 |
N-terminal asparagine amidase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NTAN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:2,111,085...2,126,123
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of NTRK2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Nudt21 |
nudix hydrolase 21 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NUDT21 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
|
|
G |
Nudt4 |
nudix hydrolase 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of NUDT4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:30,188,100...30,204,620
Ensembl chr 7:30,188,100...30,204,615
|
|
G |
Oas1a |
2'-5' oligoadenylate synthetase 1A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of OAS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
multiple interactions decreases expression |
ISO |
Isotretinoin inhibits the reaction [Benzoyl Peroxide results in increased activity of ODC1 protein] Isotretinoin results in decreased expression of ODC1 mRNA |
CTD |
PMID:15225900 PMID:15982314 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Odr4 |
odr-4 GPCR localization factor homolog |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ODR4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:62,369,109...62,424,287
Ensembl chr13:62,394,608...62,424,209
|
|
G |
Olah |
oleoyl-ACP hydrolase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of OLAH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:74,877,651...74,902,517
Ensembl chr17:74,877,655...74,902,518
|
|
G |
Olig3 |
oligodendrocyte transcription factor 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of OLIG3 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 1:14,081,259...14,083,336
Ensembl chr 1:14,081,328...14,082,149
|
|
G |
Ormdl2 |
ORMDL sphingolipid biosynthesis regulator 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ORMDL2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:1,247,869...1,250,999
Ensembl chr 7:1,246,479...1,250,907
|
|
G |
Otub2 |
OTU deubiquitinase, ubiquitin aldehyde binding 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of OTUB2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:122,545,029...122,563,651
Ensembl chr 6:122,545,061...122,563,644
|
|
G |
Pafah2 |
platelet-activating factor acetylhydrolase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PAFAH2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:146,607,050...146,636,203
Ensembl chr 5:146,613,498...146,634,943
|
|
G |
Pank3 |
pantothenate kinase 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PANK3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:20,229,129...20,252,955
Ensembl chr10:20,229,129...20,252,955
|
|
G |
Paqr3 |
progestin and adipoQ receptor family member 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PAQR3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:12,462,568...12,484,999
Ensembl chr14:12,462,563...12,479,994
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PAWR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pax6 |
paired box 6 |
increases expression |
ISO |
Isotretinoin results in increased expression of PAX6 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
|
|
G |
Pccb |
propionyl-CoA carboxylase subunit beta |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PCCB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:101,591,218...101,641,213
Ensembl chr 8:101,590,737...101,641,234
|
|
G |
Pcdh1 |
protocadherin 1 |
multiple interactions |
ISO |
[vorinostat co-treated with Isotretinoin] results in increased expression of PCDH1 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr18:30,011,692...30,039,679
Ensembl chr18:30,013,185...30,039,318
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
increases expression |
ISO |
Isotretinoin results in increased expression of PCOLCE mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
|
|
G |
Pctp |
phosphatidylcholine transfer protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PCTP mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:74,808,887...74,856,260
Ensembl chr10:74,808,887...74,849,867
|
|
G |
Pde6a |
phosphodiesterase 6A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PDE6A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:54,676,863...54,749,644
Ensembl chr18:54,676,863...54,748,816
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
increases expression |
ISO |
Isotretinoin results in increased expression of PDGFRB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pdha1 |
pyruvate dehydrogenase E1 subunit alpha 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PDHA1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:34,700,481...34,714,309
Ensembl chr X:34,700,409...34,714,311
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PDHB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pdhx |
pyruvate dehydrogenase complex, component X |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PDHX mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:89,372,472...89,396,759
Ensembl chr 3:89,371,497...89,431,773
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PDZK1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
|
|
G |
Pecr |
peroxisomal trans-2-enoyl-CoA reductase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PECR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:73,897,877...73,926,511
Ensembl chr 9:73,897,880...73,926,511
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PEX11A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pex13 |
peroxisomal biogenesis factor 13 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PEX13 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:97,602,829...97,621,233
Ensembl chr14:97,603,539...97,621,262
|
|
G |
Pex16 |
peroxisomal biogenesis factor 16 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PEX16 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:78,347,212...78,352,603
Ensembl chr 3:78,343,164...78,353,207
|
|
G |
Pex19 |
peroxisomal biogenesis factor 19 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PEX19 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:84,592,277...84,608,793
Ensembl chr13:84,592,312...84,608,608
|
|
G |
Pex3 |
peroxisomal biogenesis factor 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PEX3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:7,912,508...7,954,474
Ensembl chr 1:7,912,506...7,954,518
|
|
G |
Pex7 |
peroxisomal biogenesis factor 7 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PEX7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:14,582,698...14,646,686
Ensembl chr 1:14,582,699...14,646,748
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PGD mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pgm1 |
phosphoglucomutase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PGM1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
|
|
G |
Pgrmc1 |
progesterone receptor membrane component 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PGRMC1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:115,832,865...115,841,060
Ensembl chr X:115,832,884...115,888,682
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
increases expression |
ISO |
Isotretinoin results in increased expression of PHGDH mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:185,906,964...185,936,160
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
multiple interactions |
ISO |
[vorinostat co-treated with Isotretinoin] results in increased expression of PHLDA1 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
|
|
G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PHLDA2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836
|
|
G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PIK3C2G mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:172,483,752...172,851,623
Ensembl chr 4:172,484,345...172,850,544
|
|
G |
Pir |
pirin |
decreases expression increases expression |
ISO |
Isotretinoin results in decreased expression of PIR mRNA Isotretinoin results in increased expression of PIR mRNA |
CTD |
PMID:15982314 PMID:20436886 |
|
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PKLR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pkp1 |
plakophilin 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of PKP1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:47,309,603...47,357,551
Ensembl chr13:47,309,614...47,357,465
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PLA2G7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression |
ISO |
Isotretinoin results in increased expression of PLAT mRNA |
CTD |
PMID:15982314 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plcl2 |
phospholipase C-like 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of PLCL2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:3,292,564...3,477,009
Ensembl chr 9:3,292,695...3,477,009
|
|
G |
Plin2 |
perilipin 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PLIN2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:101,156,643...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of PLPP3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
|
|
G |
Pltp |
phospholipid transfer protein |
increases expression |
ISO |
Isotretinoin results in increased expression of PLTP mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
|
|
G |
Pmel |
premelanosome protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PMEL mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:1,138,202...1,148,735
Ensembl chr 7:1,138,586...1,148,746
|
|
G |
Pmpcb |
peptidase, mitochondrial processing subunit beta |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PMPCB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:13,297,583...13,310,363
Ensembl chr 4:13,297,559...13,310,367
|
|
G |
Pmvk |
phosphomevalonate kinase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PMVK mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PNPLA3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Polr2m |
RNA polymerase II subunit M |
increases expression |
ISO |
Isotretinoin results in increased expression of POLR2M mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:72,131,992...72,139,423
Ensembl chr 8:72,131,530...72,243,036
|
|
G |
Pon3 |
paraoxonase 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PON3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
|
|
G |
Popdc2 |
popeye domain containing 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of POPDC2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:62,351,843...62,398,688
Ensembl chr11:62,374,759...62,390,756
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression |
EXP |
Isotretinoin results in increased expression of PPARG mRNA |
CTD |
PMID:19041696 PMID:19212007 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppif |
peptidylprolyl isomerase F |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PPIF mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
|
|
G |
Ppm1b |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PPM1B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:9,646,695...9,707,471
Ensembl chr 6:9,655,765...9,707,974
|
|
G |
Ppp1r16b |
protein phosphatase 1, regulatory subunit 16B |
increases expression |
ISO |
Isotretinoin results in increased expression of PPP1R16B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:147,324,126...147,418,937
|
|
G |
Prdx2 |
peroxiredoxin 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PRDX2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prepl |
prolyl endopeptidase-like |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PREPL mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:9,580,367...9,609,957
Ensembl chr 6:9,580,217...9,607,772
|
|
G |
Pros1 |
protein S |
increases expression |
ISO |
Isotretinoin results in increased expression of PROS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
|
|
G |
Prss8 |
serine protease 8 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PRSS8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:182,536,229...182,540,745
Ensembl chr 1:182,536,229...182,540,815
|
|
G |
Psma1 |
proteasome 20S subunit alpha 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PSMA1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:168,442,421...168,453,440
Ensembl chr 1:168,440,936...168,453,472
|
|
G |
Psma3 |
proteasome 20S subunit alpha 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PSMA3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:89,483,741...89,503,775
Ensembl chr 6:89,483,727...89,504,965
|
|
G |
Psma4 |
proteasome 20S subunit alpha 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PSMA4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:55,340,431...55,347,893
Ensembl chr 8:55,340,386...55,347,890
|
|
G |
Psma5 |
proteasome 20S subunit alpha 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PSMA5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
|
|
G |
Psma7 |
proteasome 20S subunit alpha 7 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PSMA7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:167,137,279...167,143,626
Ensembl chr 3:167,137,263...167,143,672
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PSMB5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
|
|
G |
Ptgds |
prostaglandin D2 synthase |
increases expression |
ISO |
Isotretinoin results in increased expression of PTGDS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PTGS1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PTGS2 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
increases expression |
ISO |
Isotretinoin results in increased expression of PTPRB mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
|
|
G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
increases expression |
ISO |
Isotretinoin results in increased expression of PTPRC mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
|
|
G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
increases expression |
ISO |
Isotretinoin results in increased expression of PTPRG mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:12,872,284...13,552,186
Ensembl chr15:12,871,721...13,554,094
|
|
G |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
increases expression |
ISO |
Isotretinoin results in increased expression of PTPRM mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:106,639,573...107,343,698
Ensembl chr 9:106,639,573...107,343,698
|
|
G |
Ptrh2 |
peptidyl-tRNA hydrolase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PTRH2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
|
|
G |
Pts |
6-pyruvoyl-tetrahydropterin synthase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PTS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:50,870,838...50,877,878
Ensembl chr 8:50,870,841...50,877,869
|
|
G |
Pxmp2 |
peroxisomal membrane protein 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PXMP2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
|
|
G |
Pxmp4 |
peroxisomal membrane protein 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of PXMP4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:143,093,371...143,110,620
Ensembl chr 3:143,093,018...143,110,651
|
|
G |
Qki |
QKI, KH domain containing RNA binding |
increases expression |
ISO |
Isotretinoin results in increased expression of QKI mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:50,387,698...50,501,568
Ensembl chr 1:50,387,698...50,498,831
|
|
G |
Rab27a |
RAB27A, member RAS oncogene family |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RAB27A mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:73,782,730...73,836,630
Ensembl chr 8:73,782,694...73,847,829
|
|
G |
Rab38 |
RAB38, member RAS oncogene family |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RAB38 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:142,182,566...142,262,923
Ensembl chr 1:142,182,556...142,262,924
|
|
G |
Rab5if |
RAB5 interacting factor |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RAB5IF mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:145,357,990...145,368,012
Ensembl chr 3:145,357,861...145,368,012
|
|
G |
Rac2 |
Rac family small GTPase 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of RAC2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases expression decreases expression |
ISO EXP |
Isotretinoin results in increased expression of RARA mRNA Isotretinoin results in decreased expression of RARA mRNA |
CTD |
PMID:9262057 PMID:19041696 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rarb |
retinoic acid receptor, beta |
multiple interactions increases expression decreases expression |
ISO EXP |
[LAQ824 co-treated with Isotretinoin] results in increased acetylation of RARB promoter; [LAQ824 co-treated with Isotretinoin] results in increased expression of RARB mRNA; R116010 promotes the reaction [Isotretinoin results in increased expression of RARB mRNA] Isotretinoin results in decreased expression of RARB mRNA |
CTD |
PMID:17237267 PMID:17486130 PMID:19041696 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rarg |
retinoic acid receptor, gamma |
decreases expression |
EXP |
Isotretinoin results in decreased expression of RARG mRNA |
CTD |
PMID:19041696 |
|
NCBI chr 7:133,367,833...133,390,301
Ensembl chr 7:133,367,833...133,390,177
|
|
G |
Rarres1 |
retinoic acid receptor responder 1 |
multiple interactions increases expression |
ISO |
AGN 193109 inhibits the reaction [Isotretinoin results in increased expression of RARRES1 mRNA] |
CTD |
PMID:16575387 |
|
NCBI chr 2:151,749,715...151,783,975
Ensembl chr 2:151,749,715...151,783,978
|
|
G |
Rasal1 |
RAS protein activator like 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RASAL1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:35,881,269...35,913,727
Ensembl chr12:35,881,270...35,913,727
|
|
G |
Rassf2 |
Ras association domain family member 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of RASSF2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:119,244,288...119,280,462
Ensembl chr 3:119,245,821...119,280,431
|
|
G |
Rbks |
ribokinase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RBKS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:24,747,651...24,824,290
Ensembl chr 6:24,747,293...24,824,290
|
|
G |
Rbm47 |
RNA binding motif protein 47 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RBM47 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:42,053,290...42,191,572
Ensembl chr14:42,154,142...42,189,431
|
|
G |
Rbpms |
RNA binding protein, mRNA processing factor |
increases expression |
ISO |
Isotretinoin results in increased expression of RBPMS mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
|
|
G |
Rc3h2 |
ring finger and CCCH-type domains 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RC3H2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:21,121,531...21,186,711
Ensembl chr 3:21,110,679...21,179,933
|
|
G |
Rdh11 |
retinol dehydrogenase 11 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RDH11 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:97,979,377...97,995,252
Ensembl chr 6:97,979,378...97,995,252
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Isotretinoin affects the localization of and results in decreased activity of REL protein |
CTD |
PMID:18652567 PMID:19066126 |
|
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Isotretinoin affects the localization of and results in decreased activity of RELA protein |
CTD |
PMID:18652567 PMID:19066126 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Retreg1 |
reticulophagy regulator 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RETREG1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
|
|
G |
Rfk |
riboflavin kinase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RFK mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:214,799,880...214,807,440
Ensembl chr 1:214,799,825...214,807,438
|
|
G |
RGD1309104 |
similar to RIKEN cDNA 1700025G04 gene |
increases expression |
ISO |
Isotretinoin results in increased expression of C1ORF21 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:63,982,587...64,199,676
Ensembl chr13:63,990,592...64,199,596
|
|
G |
RGD1559459 |
similar to Expressed sequence AI788959 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of UGT2B28 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:21,146,140...21,167,706
Ensembl chr14:21,145,827...21,167,704
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RHOA mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rhob |
ras homolog family member B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RHOB mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of RHOBTB3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:5,363,388...5,419,164
Ensembl chr 2:5,363,388...5,419,041
|
|
G |
Rida |
reactive intermediate imine deaminase A homolog |
decreases expression |
ISO |
Isotretinoin results in decreased expression of UK114 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
|
|
G |
Riox2 |
ribosomal oxygenase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RIOX2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:40,861,365...40,884,782
Ensembl chr11:40,860,774...40,884,574
|
|
G |
Rmdn1 |
regulator of microtubule dynamics 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RMDN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:33,070,267...33,093,922
Ensembl chr 5:33,070,265...33,127,328
|
|
G |
Rnaset2 |
ribonuclease T2 |
increases expression |
ISO |
Isotretinoin results in increased expression of RNASET2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:52,576,344...52,603,151
Ensembl chr 1:52,585,929...52,603,147
|
|
G |
Rnd3 |
Rho family GTPase 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RND3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
|
|
G |
Rnf128 |
ring finger protein 128 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RNF128 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:103,183,643...103,298,431
Ensembl chr X:103,183,831...103,298,423
|
|
G |
Rnf38 |
ring finger protein 38 |
increases expression |
ISO |
Isotretinoin results in increased expression of RNF38 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:58,358,771...58,467,424
Ensembl chr 5:58,361,976...58,467,446
|
|
G |
Rnf5 |
ring finger protein 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RNF5 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr20:4,145,539...4,147,985
Ensembl chr20:4,145,507...4,147,985
|
|
G |
Ro60 |
Ro60, Y RNA binding protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RO60 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:55,499,514...55,520,504
Ensembl chr13:55,499,534...55,520,504
|
|
G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of ROR1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:114,744,311...115,088,155
Ensembl chr 5:114,744,304...115,088,155
|
|
G |
Rora |
RAR-related orphan receptor A |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RORA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
|
|
G |
Rpe65 |
retinoid isomerohydrolase RPE65 |
multiple interactions |
ISO EXP |
[Isotretinoin binds to and results in decreased activity of RPE65 protein] which results in decreased abundance of Retinaldehyde |
CTD |
PMID:16411761 |
|
NCBI chr 2:248,766,497...248,798,403
Ensembl chr 2:248,766,612...248,798,403
|
|
G |
Rpp40 |
ribonuclease P/MRP subunit p40 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RPP40 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr17:28,947,730...28,956,790
Ensembl chr17:28,947,734...28,956,788
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
increases expression |
ISO |
Isotretinoin results in increased expression of HLA-E mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
increases expression |
ISO |
Isotretinoin results in increased expression of HLA-DQB1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
RT1-CE5 |
RT1 class I, locus CE5 |
increases expression |
ISO |
Isotretinoin results in increased expression of HLA-F mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:3,403,418...3,479,476
|
|
G |
RT1-Ha |
RT1 class II, locus Ha |
increases expression |
ISO |
Isotretinoin results in increased expression of HLA-DPA1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
|
|
G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of HLA-G mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
|
|
G |
Rtca |
RNA 3'-terminal phosphate cyclase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of RTCA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:204,455,175...204,476,450
Ensembl chr 2:204,455,175...204,476,460
|
|
G |
Rtn1 |
reticulon 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of RTN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:90,763,212...90,983,436
Ensembl chr 6:90,763,216...90,983,436
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions increases activity affects binding |
ISO EXP |
Isotretinoin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] Isotretinoin results in increased activity of RXRA protein Isotretinoin binds to RXRA protein |
CTD |
PMID:16632523 PMID:21543282 PMID:31566444 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Rxrb |
retinoid X receptor beta |
decreases expression |
EXP |
Isotretinoin results in decreased expression of RXRB mRNA |
CTD |
PMID:19041696 |
|
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
|
|
G |
S100a1 |
S100 calcium binding protein A1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of S100A1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
|
|
G |
S100a4 |
S100 calcium-binding protein A4 |
increases expression |
ISO |
Isotretinoin results in increased expression of S100A4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
increases expression |
ISO |
Isotretinoin results in increased expression of S100A8 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
increases expression |
ISO |
Isotretinoin results in increased expression of S100A9 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
|
|
G |
Samm50 |
SAMM50 sorting and assembly machinery component |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SAMM50 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:115,317,472...115,341,682
Ensembl chr 7:115,317,404...115,341,682
|
|
G |
Samsn1 |
SAM domain, SH3 domain and nuclear localization signals, 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of SAMSN1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900
|
|
G |
Sar1b |
secretion associated, Ras related GTPase 1B |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SAR1B mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:36,024,443...36,054,067
Ensembl chr10:36,024,382...36,054,066
|
|
G |
Sc5d |
sterol-C5-desaturase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SC5D mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G |
Scamp1 |
secretory carrier membrane protein 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SCAMP1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:25,433,958...25,516,734
Ensembl chr 2:25,433,959...25,516,673
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
increases expression |
ISO |
Isotretinoin results in increased expression of SCNN1A mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
|
|
G |
Sdf2l1 |
stromal cell-derived factor 2-like 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SDF2L1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
|
|
G |
Sdhc |
succinate dehydrogenase complex subunit C |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SDHC mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:83,544,652...83,565,560
Ensembl chr13:83,544,652...83,566,253
|
|
G |
Selplg |
selectin P ligand |
increases expression |
ISO |
Isotretinoin results in increased expression of SELPLG mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585
|
|
G |
Septin11 |
septin 11 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SEPTIN11 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:14,844,759...14,990,856
Ensembl chr14:14,844,580...14,990,853
|
|
G |
Serhl2 |
serine hydrolase-like 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of SERHL2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:114,246,056...114,272,781
Ensembl chr 7:114,246,056...114,272,781
|
|
G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
increases expression |
ISO |
Isotretinoin results in increased expression of SERPINA3 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 6:123,323,632...123,331,166
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Serpinb2 |
serpin family B member 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SERPINB2 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
|
|
G |
Serpinb8 |
serpin family B member 8 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SERPINB8 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr13:23,626,945...23,650,270
Ensembl chr13:23,626,945...23,650,835
|
|
G |
Serpinb9 |
serpin family B member 9 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SERPINB9 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
|
|
G |
Serpine1 |
serpin family E member 1 |
decreases expression |
EXP |
Isotretinoin results in decreased expression of SERPINE1 mRNA |
CTD |
PMID:15972972 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serping1 |
serpin family G member 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of SERPING1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SGK2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
|
|
G |
Shh |
sonic hedgehog signaling molecule |
increases expression |
ISO |
Isotretinoin results in increased expression of SHH mRNA |
CTD |
PMID:26096596 |
|
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Shmt1 |
serine hydroxymethyltransferase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SHMT1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:45,468,698...45,497,820
Ensembl chr10:45,468,700...45,497,820
|
|
G |
Sirpa |
signal-regulatory protein alpha |
increases expression |
ISO |
Isotretinoin results in increased expression of SIRPA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:116,819,730...116,858,099
Ensembl chr 3:116,819,726...116,858,098
|
|
G |
Skic8 |
SKI8 subunit of superkiller complex |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SKIC8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:55,103,542...55,120,837
Ensembl chr 8:55,103,545...55,120,813
|
|
G |
Sla |
src-like adaptor |
increases expression |
ISO |
Isotretinoin results in increased expression of SLA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC11A2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC15A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC16A1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc16a7 |
solute carrier family 16 member 7 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC16A7 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC22A18 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Slc25a11 |
solute carrier family 25 member 11 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC25A11 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:55,358,163...55,360,278
Ensembl chr10:55,357,597...55,360,410
|
|
G |
Slc25a15 |
solute carrier family 25 member 15 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC25A15 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:69,631,581...69,654,869
Ensembl chr16:69,634,414...69,653,010
|
|
G |
Slc25a16 |
solute carrier family 25 member 16 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC25A16 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:25,661,158...25,717,558
Ensembl chr20:25,662,055...25,716,319
|
|
G |
Slc25a17 |
solute carrier family 25 member 17 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC25A17 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:112,844,375...112,887,014
Ensembl chr 7:112,844,375...112,925,945
|
|
G |
Slc26a3 |
solute carrier family 26 member 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC26A3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
|
|
G |
Slc27a2 |
solute carrier family 27 member 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC27A2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
increases expression |
EXP |
Isotretinoin results in increased expression of SLC2A4 mRNA |
CTD |
PMID:19212007 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC30A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc30a10 |
solute carrier family 30, member 10 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC30A10 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:96,998,143...97,048,076
Ensembl chr13:96,998,143...97,009,103
|
|
G |
Slc31a1 |
solute carrier family 31 member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC31A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
|
|
G |
Slc35a2 |
solute carrier family 35 member A2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC35A2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:14,608,145...14,616,937
Ensembl chr X:14,608,055...14,616,678
|
|
G |
Slc35b1 |
solute carrier family 35, member B1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC35B1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,327,945...80,335,274
|
|
G |
Slc39a14 |
solute carrier family 39 member 14 |
increases expression |
ISO |
Isotretinoin results in increased expression of SLC39A14 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
|
|
G |
Slc39a8 |
solute carrier family 39 member 8 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC39A8 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
|
|
G |
Slc46a3 |
solute carrier family 46, member 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC46A3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
|
|
G |
Slc50a1 |
solute carrier family 50 member 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC50A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:174,677,985...174,680,366
Ensembl chr 2:174,677,708...174,680,366
|
|
G |
Slc5a6 |
solute carrier family 5 member 6 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC5A6 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLC7A5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slco4c1 |
solute carrier organic anion transporter family, member 4C1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SLCO4C1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:97,180,162...97,229,135
Ensembl chr 9:97,178,861...97,229,715
|
|
G |
Slit3 |
slit guidance ligand 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of SLIT3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr10:19,571,798...20,156,634
Ensembl chr10:19,571,684...20,156,634
|
|
G |
Smyd3 |
SET and MYND domain containing 3 |
increases expression |
ISO |
Isotretinoin results in increased expression of SMYD3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:90,709,263...91,266,209
Ensembl chr13:90,709,270...91,266,253
|
|
G |
Sned1 |
sushi, nidogen and EGF-like domains 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of SNED1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:93,774,087...93,834,003
Ensembl chr 9:93,774,119...93,830,694
|
|
G |
Snx13 |
sorting nexin 13 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SNX13 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 6:51,758,258...51,862,260
Ensembl chr 6:51,753,036...51,860,224
|
|
G |
Soat1 |
sterol O-acyltransferase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SOAT1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr13:68,552,274...68,597,529
Ensembl chr13:68,552,317...68,597,494
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SOCS1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of SOCS2 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SOD2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SORBS1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
|
|
G |
Sord |
sorbitol dehydrogenase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SORD mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
|
|
G |
Sort1 |
sortilin 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SORT1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:195,924,033...196,002,354
Ensembl chr 2:195,924,099...196,002,354
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
decreases localization |
ISO |
Isotretinoin results in decreased localization of SOX17 protein |
CTD |
PMID:24154490 |
|
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
|
|
G |
Spcs3 |
signal peptidase complex subunit 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SPCS3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr16:37,305,358...37,310,792
Ensembl chr16:37,305,305...37,331,746
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of SPP1 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Spred2 |
sprouty-related, EVH1 domain containing 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of SPRED2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:94,226,312...94,248,162
Ensembl chr14:94,148,837...94,249,162
|
|
G |
Sprr1b |
small proline-rich protein 1B |
increases expression |
ISO |
Isotretinoin results in increased expression of SPRR1B mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 2:178,009,130...178,009,567
Ensembl chr 2:178,009,130...178,009,567
|
|
G |
Sprr3 |
small proline-rich protein 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SPRR3 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 2:178,027,743...178,028,501
Ensembl chr 2:178,027,425...178,029,891
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SRD5A1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Srpx2 |
sushi-repeat-containing protein, X-linked 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SRPX2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr X:97,106,455...97,132,197
Ensembl chr X:97,106,561...97,132,195
|
|
G |
St6galnac4 |
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of ST6GALNAC4 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243
|
|
G |
Stambp |
Stam binding protein |
decreases expression |
ISO |
Isotretinoin results in decreased expression of STAMBP mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:116,055,563...116,083,563
Ensembl chr 4:116,056,057...116,080,543
|
|
G |
Stap2 |
signal transducing adaptor family member 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of STAP2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 9:828,369...838,648
Ensembl chr 9:828,372...837,219
|
|
G |
Stip1 |
stress-induced phosphoprotein 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of STIP1 mRNA |
CTD |
PMID:18769122 |
|
NCBI chr 1:204,209,434...204,228,452
Ensembl chr 1:204,178,932...204,228,476
|
|
G |
Suclg1 |
succinate-CoA ligase GDP/ADP-forming subunit alpha |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SUCLG1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:105,308,236...105,337,595
Ensembl chr 4:105,308,039...105,337,600
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of SULT2A1 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 1:75,451,178...75,508,142
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Susd5 |
sushi domain containing 5 |
increases expression |
ISO |
Isotretinoin results in increased expression of SUSD5 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:113,996,771...114,036,133
Ensembl chr 8:113,997,362...114,035,861
|
|
G |
Syn2 |
synapsin II |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SYN2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192
|
|
G |
Syngr1 |
synaptogyrin 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of SYNGR1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 7:111,635,911...111,659,341
Ensembl chr 7:111,635,918...111,659,341
|
|
G |
Tacstd2 |
tumor-associated calcium signal transducer 2 |
increases expression |
ISO |
Isotretinoin results in increased expression of TACSTD2 mRNA |
CTD |
PMID:15982314 |
|
NCBI chr 4:96,707,950...96,709,650
Ensembl chr 4:96,707,951...96,709,650
|
|
G |
Tagln |
transgelin |
increases expression multiple interactions |
ISO |
Isotretinoin results in increased expression of TAGLN mRNA [LAQ824 co-treated with Isotretinoin] results in increased expression of TAGLN mRNA |
CTD |
PMID:17237267 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tagln3 |
transgelin 3 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TAGLN3 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:55,099,887...55,113,457
Ensembl chr11:55,099,743...55,113,485
|
|
G |
Taldo1 |
transaldolase 1 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TALDO1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 1:196,493,634...196,503,965
Ensembl chr 1:196,493,589...196,503,974
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of TBC1D1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr14:43,936,820...44,135,133
Ensembl chr14:43,935,636...44,136,499
|
|
G |
Tbl1xr1 |
TBL1X/Y related 1 |
increases expression |
ISO |
Isotretinoin results in increased expression of TBL1XR1 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
|
|
G |
Tcf15 |
transcription factor 15 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TCF15 mRNA |
CTD |
PMID:31711903 |
|
NCBI chr 3:140,638,984...140,644,766
Ensembl chr 3:140,638,984...140,644,766
|
|
G |
Tcta |
T-cell leukemia translocation altered |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TCTA mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:108,988,588...108,992,324
Ensembl chr 8:108,988,590...108,991,564
|
|
G |
Tecr |
trans-2,3-enoyl-CoA reductase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TECR mRNA |
CTD |
PMID:20436886 |
|
NCBI chr19:24,526,705...24,568,168
Ensembl chr19:24,541,615...24,568,168
|
|
G |
Tent5c |
terminal nucleotidyltransferase 5C |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TENT5C mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 2:187,853,026...187,875,260
Ensembl chr 2:187,853,024...187,894,744
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TERT mRNA |
CTD |
PMID:16180984 |
|
NCBI chr 1:29,637,213...29,659,509
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tfdp2 |
transcription factor Dp-2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TFDP2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
|
|
G |
Tff2 |
trefoil factor 2 |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TFF2 mRNA |
CTD |
PMID:20436886 |
|
NCBI chr20:9,215,750...9,219,619
Ensembl chr20:9,215,761...9,219,619
|
|
G |
Tfrc |
transferrin receptor |
decreases expression |
ISO |
Isotretinoin results in decreased expression of TFRC mRNA |
CTD |
PMID:20436886 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
EXP |
Isotretinoin results in decreased expression of TGFB1 mRNA |
CTD |
PMID:15972972 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
| |